SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-215714
Filing Date
2020-08-11
Accepted
2020-08-11 08:30:29
Documents
3
Period of Report
2020-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d87567d8k.htm 8-K 17403
2 EX-99.1 d87567dex991.htm EX-99.1 118756
3 GRAPHIC g87567dsp1.jpg GRAPHIC 2768
  Complete submission text file 0001193125-20-215714.txt   141235
Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Filer) CIK: 0001805890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39344 | Film No.: 201091159
SIC: 2836 Biological Products, (No Diagnostic Substances)